High and Very High Cardiovascular Risk Associated with Albuminuria/Creatinuria Ratio in Type 2 Diabetes

Abstract

Objective: To determine the association of high and very high cardiovascular risk by Globorisk with albuminuria-creatinuria ratio in patients living with type 2 Diabetes. Methods: A descriptive, observational, cross-sectional, prospective study was conducted at the General Hospital / Family Medicine No. 12 of Lazaro Cardenas, Michoacan, Mexico, of the Mexican Social Security Institute; in 375 beneficiaries with type 2 diabetes, from February 2024 to February 2025. Results: 375 patients with type 2 diabetes were studied, average age 62 + 8 years, with high and very high Cardiovascular Risk by Globorisk, no significant association was found with the Albuminuria/Creatinuria Ratio (RACU) (p = 0.5). A predominance of slightly increased RACU (48.5%) was observed, with a very high Globorisk (59%). Conclusions: Our study showed that 55% of patients with high and very high GloboRisk had moderately and highly increased RACU. The results suggest that using GloboRisk in combination with RACU provides a comprehensive approach to assessing endothelial damage and target organ involvement in diabetic patients as prognostic factors.